Cargando…
FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
Low‐grade gliomas (LGGs) are grade III gliomas based on the WHO classification with significant genetic heterogeneity and clinical properties. Traditional histological classification of gliomas has been challenged by the improvement of molecular stratification; however, the reproducibility and diagn...
Autores principales: | Wang, Yichang, Wahafu, Alafate, Wu, Wei, Xiang, Jianyang, Huo, Longwei, Ma, Xudong, Wang, Ning, Liu, Hao, Bai, Xiaobin, Xu, Dongze, Xie, Wanfu, Wang, Maode, Wang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093984/ https://www.ncbi.nlm.nih.gov/pubmed/33837625 http://dx.doi.org/10.1111/jcmm.16536 |
Ejemplares similares
-
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas
por: Wu, Wei, et al.
Publicado: (2021) -
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022) -
A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022) -
Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling
por: Alafate, Wahafu, et al.
Publicado: (2020) -
Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)